Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018


April 12, 2012
86 Pages - SKU: GBDT3865607
License type:
Countries covered: Global

Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData’s new report, “Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global Point of Care (POC) diagnostics market. The report provides market landscape, competitive landscape and market trends information on the POC diagnostics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, and Japan.
  • Key segments covered include Clinical Chemistry, Immuno Chemistry and Hematology.
  • Annualized market revenues data from forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within point of care diagnostics market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include F. Hoffmann-La Roche Ltd., Alere, Inc., Siemens Healthcare and Abbott Laboratories.
Reasons to buy
  • Develop business strategies by understanding the trends and developments that are driving the POC diagnostics market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What’s the next big thing in the POC diagnostics market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global POC diagnostics market and the factors shaping it.



More Diagnostics reports by GlobalData

XEPTAGEN SpA - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryXeptagen SpA (Xeptagen) is a healthcare company. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of ...
Hycor Biomedical Inc. - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryHycor Biomedical Inc. (Hycor) is a medical diagnostic company. The company manufactures and markets diagnostic products used in clinical laboratories. It offers urinalysis, allergy testing ...
Great Basin Corporation - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryGreat Basin Corporation (Great Basin) is a life science company. The company develops and distributes point-of-care technology and products which improve automation, throughput, scalability, reliability ...
Focus Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryFocus Diagnostics, Inc. (Focus Diagnostics) is a medical device company. The company manufactures and distributes molecular and immunology products. Its products include 3M integrated cycler, ...
See all reports like this >>

More Global Diagnostics reports

Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component – Global Forecasts to 2017 by MarketsandMarkets
The global healthcare IT market is estimated to grow at a CAGR of 7.0% to reach $ 56.7 billion by 2017 from $40.4 billion in ...
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives by Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where ...
Global Molecular Diagnostics Market 2012-2016 by Infiniti Research Limited
Global Molecular Diagnostics Market 2012-2016TechNavio's analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One ...
Global Biochips Market 2012-2016 by Infiniti Research Limited
Global Biochips Market 2012-2016TechNavio's analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the ...
See all reports like this >>